Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1200 participants
OBSERVATIONAL
2017-02-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this trial is to implement record of posterior ECG leads (V7, V8 and V9) in addition to the standard 12-lead ECG in the pre-hospital setting and to evaluate the clinical impact of this implementation: In comparison to a control cohort of STEMI patients diagnosed with a pre-hospital standard 12-lead ECG prior study start, the investigators hypothesize that introducing V7-V9 leads as a clinical routine in the pre-hospital setting will identify patients with STEMI involving LCX and with a non-diagnostic standard 12-lead ECG.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ECG Identifying the Culprit Coronary Artery
NCT03387280
Diagnostic Accuracy of Electrocardiogram for Acute Coronary Occlusion Resulting in Myocardial Infarction
NCT04022668
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
NCT06860997
Left Bundle Branch Block ECG Characteristics in the Evaluation of Acute Coronary Syndrome
NCT02283619
Contrast Echocardiography in Non-ST Elevation Myocardial Infarction
NCT01122069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Standard 12-Lead ECG
Conventional record of Standard 12-lead ECG in every patient with suspect of acute coronary syndrome.
Intervention
Standard 12-Lead ECG
Conventional record of Standard 12-lead ECG in every patient with suspect of acute coronary syndrome.
Posterior ECG Leads
Recording posterior ECG leads (V7, V8 and V9) in addition to standard 12-lead ECG for identifying STEMI involving left cirumflex coronary artery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard 12-Lead ECG
Conventional record of Standard 12-lead ECG in every patient with suspect of acute coronary syndrome.
Posterior ECG Leads
Recording posterior ECG leads (V7, V8 and V9) in addition to standard 12-lead ECG for identifying STEMI involving left cirumflex coronary artery.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nykøbing Falster County Hospital
OTHER
Region Sjælland
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yama Fakhri
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens Kastrup, MD,Professor
Role: STUDY_CHAIR
Dept of Cardiology, Rigshospitalet, Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Jens Kastrup, MD, Professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yama Fakhri, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLAWLESS-16-YF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.